Last 39 quarters of trend data · Healthcare · Life Science Tools
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.11 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.89 | 1.54 | 1.14 | 1.70 | 1.56 | 2.64 | 2.08 | 3.00 | 3.52 | 3.71 | 7.06 | 8.30 | 8.23 | 6.85 | 3.72 | 5.02 | 3.87 | 6.38 | 9.10 | 12.84 | 17.04 |
| — | -41.7% | -45.5% | -43.5% | -55.7% | -28.7% | -70.5% | -63.8% | -57.2% | -45.8% | +89.6% | +65.2% | +112.7% | +7.3% | -59.1% | -60.9% | -77.3% | -69.6% | -50.8% | -8.9% | +89.5% | |
| P/B Ratio | 0.42 | 0.86 | 0.59 | 1.01 | 0.80 | 0.88 | 0.80 | 1.24 | 1.47 | 1.50 | 2.63 | 2.96 | 2.89 | 2.38 | 1.18 | 1.44 | 1.09 | 1.47 | 2.52 | 3.53 | 3.99 |
| — | -3.3% | -26.4% | -19.0% | -45.9% | -41.2% | -69.7% | -58.1% | -49.2% | -36.8% | +123.5% | +105.9% | +164.4% | +61.4% | -53.3% | -59.3% | -72.6% | -67.8% | -40.9% | -50.7% | -21.2% | |
| P/FCF | — | 20.37 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.7% | 38.5% | 42.7% | 45.5% | 42.6% | 46.1% | 54.0% | 61.9% | 55.8% | 64.4% | 57.5% | 52.7% | 60.9% | 61.5% | 59.2% | 48.3% | 40.4% | 36.9% | 49.3% | 54.6% | 53.4% |
| — | -16.5% | -20.9% | -26.5% | -23.5% | -28.4% | -6.0% | +17.4% | -8.4% | +4.8% | -2.8% | +9.1% | +50.5% | +66.8% | +20.1% | -11.5% | -24.2% | -32.6% | -18.0% | -9.5% | -18.0% | |
| Operating Margin | -79.2% | -150.2% | -59.1% | -54.4% | -93.0% | -151.7% | -87.1% | -43.3% | -33.2% | -32.1% | -47.7% | -54.3% | -41.2% | -31.0% | -33.4% | -85.7% | -138.8% | -106.5% | -61.5% | -65.7% | -57.1% |
| — | +1.0% | +32.1% | -25.7% | -180.2% | -373.2% | -82.7% | +20.3% | +19.5% | -3.5% | -42.9% | +36.6% | +70.3% | +70.9% | +45.8% | -30.5% | -143.2% | -97.8% | -71.1% | -72.8% | -838.4% | |
| Net Margin | -77.3% | -148.7% | -48.2% | -52.7% | -83.5% | -122.7% | -67.7% | -34.1% | -23.6% | -21.6% | -35.1% | -39.8% | -21.6% | -19.6% | -21.6% | -72.6% | -133.0% | -106.3% | -61.4% | -66.1% | -58.7% |
| — | -21.2% | +28.9% | -54.6% | -253.9% | -467.0% | -92.9% | +14.3% | -9.1% | -10.2% | -62.4% | +45.2% | +83.7% | +81.5% | +64.8% | -9.7% | -126.6% | -126.7% | -65.4% | -75.9% | -885.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -34.2% | -18.8% | -6.1% | -7.6% | -11.0% | -9.9% | -6.3% | -3.5% | -2.5% | -2.2% | -3.2% | -3.5% | -1.9% | -1.7% | -1.7% | -5.1% | -9.0% | -6.0% | -4.2% | -4.5% | -3.4% |
| — | -91.1% | +4.3% | -117.9% | -346.6% | -352.6% | -96.5% | +1.5% | -30.5% | -28.0% | -89.2% | +30.6% | +79.0% | +71.6% | +59.2% | -13.8% | -165.1% | -135.9% | -40.4% | +5.6% | -346.9% | |
| ROA | -26.0% | -14.3% | -4.5% | -5.4% | -8.2% | -7.8% | -5.1% | -2.8% | -2.0% | -1.8% | -2.7% | -2.9% | -1.6% | -1.4% | -1.4% | -4.2% | -7.5% | -5.0% | -3.6% | -3.9% | -3.0% |
| — | -83.4% | +12.5% | -88.4% | -302.5% | -333.1% | -92.2% | +1.7% | -29.8% | -26.8% | -87.4% | +31.5% | +79.1% | +71.8% | +60.5% | -7.2% | -148.7% | -123.5% | -42.8% | -7.3% | -392.2% | |
| ROIC | -26.8% | -14.6% | -5.5% | -5.8% | -10.9% | -11.8% | -6.7% | -3.4% | -2.6% | -2.5% | -4.1% | -6.2% | -7.3% | -10.1% | -10.4% | -24.3% | -33.9% | -20.0% | -16.6% | -22.0% | -17.0% |
| — | -23.7% | +18.0% | -71.8% | -320.8% | -379.0% | -64.1% | +45.6% | +64.3% | +75.7% | +60.6% | +74.6% | +78.5% | +49.2% | +37.4% | -10.4% | -99.5% | -21.5% | -30.0% | -115.3% | -812.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.14 | 0.13 | 0.13 | 0.13 | 0.12 | 0.12 | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.05 | 0.05 |
| — | +15.8% | +8.8% | +11.2% | +12.3% | +3.4% | -2.9% | -4.4% | -5.3% | -3.7% | -4.4% | -3.8% | +4.1% | +8.0% | +16.3% | +148.2% | +116.8% | +74.1% | +64.7% | -66.8% | -79.5% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.84 | 3.40 | 3.72 | 2.84 | 3.02 | 6.68 | 8.29 | 8.66 | 10.07 | 9.74 | 11.38 | 9.80 | 10.84 | 11.87 | 13.96 | 12.17 | 13.54 | 11.27 | 13.65 | 12.14 | 14.73 |
| — | -49.2% | -55.1% | -67.2% | -70.0% | -31.4% | -27.1% | -11.7% | -7.1% | -17.9% | -18.5% | -19.5% | -19.9% | +5.3% | +2.3% | +0.2% | -8.1% | -10.9% | +3.2% | +120.1% | +92.5% | |
| Quick Ratio | 2.11 | 2.45 | 2.70 | 2.11 | 2.31 | 6.06 | 7.53 | 7.88 | 9.16 | 8.99 | 10.57 | 9.13 | 10.27 | 11.30 | 13.32 | 11.63 | 12.90 | 10.67 | 12.94 | 11.54 | 14.00 |
| — | -59.5% | -64.1% | -73.3% | -74.8% | -32.6% | -28.8% | -13.8% | -10.8% | -20.4% | -20.7% | -21.5% | -20.4% | +5.9% | +3.0% | +0.8% | -7.9% | -11.7% | +1.4% | +124.4% | +95.0% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -169.26 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 39 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying QTRX stock.
Quanterix Corporation's current P/E is -1.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quanterix Corporation's current operating margin is -79.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Quanterix Corporation's business trajectory between earnings reports.